Pituitary CRH receptor blockade reduces waking in the rat

Physiology and Behavior

Volumn 67, Issue 5, 1999, Pages 691-696

  Chang, Fang Chia ^a   Opp, Mark R ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Antagonist; Astressin; EEG; HPA axis; Sleep; Helical CRH

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SLEEP; SLEEP WAKING CYCLE;

EID: 0032715489     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00139-0     Document Type: Article

References (27)

1. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berlin). 103:1991;227-232.
2. Ban E., Marquette C., Sarrieau A., Fitzpatrick F., Fillion G., Milon G., Rostene W., Haour F. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology. 58:1993;581-587.
3. Chang F.-C., Opp M.R. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am. J. Physiol. 275:1998;R793-R802.
4. Diamant M., De Wied D. Structure-related effects of CRF and CRF-derived peptides. Dissociation of behavioral, endocrine and autonomic activity Neuroendocrinology. 57:1993;1071-1081.
5. Dieterich K.D., Lehnert H., De Souza E.B. Corticotropin-releasing factor receptors. An overview Exp. Clin. Endocrinol. Diabetes. 105:1997;65-82.
6. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration. Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
7. 9-41 in three bioassay systems. Endocrinology. 129:1991;1312-1316.
8. Gillin J.C., Jacobs L.S., Snyder F., Henkin R.I. Effects of decreased adrenal corticosteroids. Changes in sleep in normal subjects and patients with adrenal cortical insufficiency Electroencephalogr. Clin. Neurophysiol. 36:1974;283-289.
9. Keller-Wood M., Dallman J. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5:1984;1-24.
10. Lee S.W., Tsou A.-P., Chan H., Thomas J., Petrie K., Eugui E.M., Allison A.C. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. USA. 85:1988;1204-1208.
11. Martins J.M., Kastin A.J., Banks W.A. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology. 63:1996;338-348.
12. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 269:1994;564-572.
13. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44.
14. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv. Neuroimmunol. 5:1995;127-143.
15. Opp M.R. Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep. Physiol. Behav. 63:1997;67-74.
16. Opp M.R., Krueger J.M. Interleukin-1 involvement in the regulation of sleep. Rothwell N.J., Dantzer R.D. Interleukin-1 in the brain. 1992;151-171 Pergamon Press, Oxford.
17. Opp M.R., Obál F., Krueger J.M. Interleukin-1 alters rat sleep. Temporal and dose-related effects Am. J. Physiol. 260:1991;R52-R58.
18. Opp M.R., Toth L.A. Somnogenic and pyrogenic effects of interleukin-1β and lipopolysaccharide in intact and vagotomized rats. Life Sci. 62:1998;923-936.
19. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:1991;425-473.
20. Pezeshki G., Pohl T., Schöbitz B. Corticosterone controls interleukin-1β expression and sickness behavior in the rat. J. Neuroendocrinol. 8:1996;129-135.
21. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:1994;8777-8781.
22. Rivier C., Rivier J., Lee S. Importance of pituitary and brain receptors for corticotropin- releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res. 721:1996;83-90.
23. Taishi P., Bredow S., Guha-Thakurta N., Obál F. Jr., Krueger J.M. Diurnal variations of interleukin-1β mRNA and β-actin mRNA in rat brain. J. Neuroimmunol. 75:1997;69-74.
24. Turnbull A.V., Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress. CRF receptors, binding protein, and related peptides PSEBM. 215:1997;1-10.
25. Vale W., Vaughan J., Perrin M. Corticotropin-releasing factor (CRF) family of ligands and their receptors. Endocrinologist. 7:1997;3s-9s.
26. Winslow J.T., Newman J.D., Insel T.R. CRH and alpha-helical-CRH modulate behavioral measures of arousal in monkeys. Pharmacol. Biochem. Behav. 32:1989;919-926.
27. Yokoe T., Audhya T., Brown C., Hutchinson B., Passarelli J., Hollander C.S. Corticotropin-releasing factor levels in the peripheral plasma and hypothalamus of the rat vary in parallel with changes in the pituitary-adrenal axis. Endocrinology. 123:1988;1348-1354.